OneSource Specialty Pharma Limited (NSE: ONESOURCE) announced strong Q4 FY26 results with revenue up 47% QoQ and EBITDA expanding more than 5x.
Cipla Limited (CIPLA) announced its Q4 FY26 results with robust growth in One India, North America, and One Africa segments.
Sakar Healthcare Limited (SAKAR) records 42% YoY revenue growth in Q4 FY26, with EBITDA rising 67%.
Sagility Limited (NSE: SAGILITY) reports strong FY26 performance with 29.1% revenue growth and 39.5% Adjusted PAT increase.
Sagility Limited (NSE: SAGILITY) reports Q4 FY26 results with 29% revenue growth, driven by AI orchestration and new client wins.
Dr. Reddy's Laboratories Limited DRREDDY reports strong Q4 & FY26 results with double-digit growth and strategic milestones.
Cohance Lifesciences Limited (COHANCE) reports FY26 Q4 results, showcasing strategic growth alignment and a transition year outlook for FY27.
Neuland Laboratories Limited reported a strong Q4FY26 with total income rising to Rs. 2053.1 crore, up 134.9%. EBITDA also surged.
Suven Life Sciences Limited reaches 76% enrollment in its Global Phase 3 Masupirdine trial for Alzheimer’s agitation.
Park Medi World Limited announces record Q4 & 12M FY’26 results, with 27% YoY net profit growth and 21% revenue increase.